Item 8.01. Other Events.
On December 21, 2022, Venus Concept Inc. (the "Company") issued a press release
relating to its receipt of 510(k) clearance from the U.S. Food and Drug
Administration (the "FDA") to market AI.ME, the Company's next generation
robotic technology, for fractional skin resurfacing. A copy of the press release
regarding the above-described FDA clearance is attached as Exhibit 99.1 to this
Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
Exhibit
No. Description
99.1 Press release dated December 21, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses